Tech Company Financing Transactions
KayoThera Funding Round
On 7/19/2023, KayoThera raised $5.2 million in Series A funding from Accelerator Life Science Partners, BioAdvance Ventures and New Jersey Health Foundation.
Transaction Overview
Company Name
Announced On
7/19/2023
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Series A
Investors
Accelerator Life Science Partners (Lead Investor) (Ken Mohler)
Proceeds Purpose
KayoThera, Inc. is an early-stage therapeutics company focused on the development of first-in-class, oral, small molecule inhibitors of the retinoid pathway. This pathway plays a critical role in a variety of serious diseases, including cardiometabolic diseases and cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Princeton, NJ 08540
United States
Princeton, NJ 08540
United States
Phone
Undisclosed
Website
Email Address
Overview
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Ian Howes
Co-Founder
Mark Esposito
President
Thong Q. Le
Browse more venture capital transactions:
Prev: 7/19/2023: Manta Network venture capital transaction
Next: 7/19/2023: Cosmic Wire venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs